2025.02.12

Genomtec to issue shares to raise funds to support commercialization of projects

The company’s shareholder – 5HT FR intends to sell 1.3 million existing shares of the company in a public offering and use the entire ...
2025.01.28

Genomtec has filed a second patent application for the OncoSNAAT oncology project

Genomtec SA announced today that it has filed a patent application with the British Patent Office for an innovative technology for the diagnosis ...
2024.06.25

Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

Dear Investors GENOMTEC S.A. invite you to an investor webinar discussing the market in which the company operates and trends in the M&A ...
2024.04.22

Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

Genomtec S.A., announces that the Extraordinary General Meeting of Shareholders of the company appointed Dr. Trevor Hawkins to the Supervisory ...
2024.03.26

Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project – Company will raise capital from founding shareholders and investors

Genomtec will raise PLN 10.6 million (equivalent to over USD 2.6 million), most of which will be used to fund the research & development of ...
2024.03.12

Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Genomtec S.A.,  announces that the Extraordinary General Meeting of Shareholders of the company has appointed two new members to the Supervisory ...